Skip to content

Clinical trials

Phase 3 Epilepsies, Myoclonic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20155
20163
20173
20191
20203
20212
20222
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated8
Recruiting2
Withdrawn2
Enrolling by invitation1
Unknown status1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals4
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.4
Takeda3
H. Lundbeck A/S2
INSYS Therapeutics Inc2
Longboard Pharmaceuticals2
Eisai Inc.1
Epygenix1
GW Research Ltd1
Stoke Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic25
Epilepsy12
Seizures11
Lennox Gastaut Syndrome8
Brain Diseases4
Neurodevelopmental Disorders2
Spasms, Infantile1
Tuberous Sclerosis1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.